Qualitative and quantitative compostion:
Each tablet contains 25 mg tetrabenazine.
Excipient: Each tablet also contains 64 mg of lactose monohydrate.
Therapeutic indications:
Movement disorders associated with organic central nervous system conditions, e.g., Huntington’s chorea, hemiballismus and senile chorea.
Xenazine 25 is also indicated for the treatment of moderate to severe tardive dyskinesia.
